Building Better Beta Cells

descriptionPublicationkeyboard_double_arrow_right Article , Other literature type 01 Apr 2008 English Publisher:Elsevier BVJournal:Cell Stem Cell, volume 2, pages 300-301 (issn: 1934-5909,

Copyright policy )

Authors: Stanley, Edouard G.; Elefanty, Andrew G.;

doi: 10.1016/j.stem.2008.03.011

pmid: 18397747

Building Better Beta Cells

- Summary
- Subjects
- Metrics

Abstract

Type 1 diabetes represents an attractive target for human embryonic stem cell (hESC)-based cell replacement therapies. Recently, in Nature Biotechnology, Kroon et al. (2008) reported encouraging progress toward this goal with the development of functional islet-like structures in mice transplanted with hESC-derived pancreatic endoderm.

Related Organizations

Monash University, Clayton campus
Australia
Monash University
Australia

Keywords

Diabetes Mellitus, Type 1, Insulin-Secreting Cells, Genetics, Molecular Medicine, Animals, Humans, Cell Biology, Embryonic Stem Cells, Stem Cell Transplantation

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	7
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%